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Abstract
Background
In 2005 a cluster of 53 HIV-infected patients with extensively drug-resistant tuberculosis (XDR-TB) was
detected in the Msinga sub-district, the catchment area for the Church of Scotland Hospital (CoSH) in Tugela
Ferry, in KwaZulu-Natal province (KZN), South Africa. KZN is divided into 11 healthcare districts. We
sought to determine the distribution of XDR TB cases in the province in relation to population density.
Methods
In this cross-sectional study, the KZN tuberculosis laboratory database was analysed. Results of all patients
with a sputum culture positive for Mycobacterium tuberculosis from January 2006 to June 2007 were included.
Drug-susceptibility test results for isoniazid, rifampicin, ethambutol, streptomycin, kanamycin and ofloxacin
were available for all patients as well as the location of the hospital where their clinical diagnosis was made.
Findings
In total, 20858 patients attending one of 73 hospitals or their adjacent clinics had cultures positive for M.
tuberculosis. Of these, 4170 (20%) were MDR-TB cases. Four hundred and forty three (11%) of the MDR
tuberculosis cases displayed the XDR tuberculosis susceptibility profile. Only 1429 (34%) of the MDR-TB
patients were seen at the provincial referral hospital for treatment. The proportion of XDR-TB amongst
culture-confirmed cases was highest in the Msinga sub-district (19.6%), followed by the remaining part of the
Umzinyati district (5.9%) and the other 10 districts (1.1%). The number of hospitals with at least one XDR-
TB case increased from 18 (25%) to 58 (80%) during the study period.
Interpretation
XDR-TB is present throughout KZN. More than 65% of all diagnosed MDR-TB cases, including XDR-TB
patients, were left untreated and likely remained in the community as a source of infection.
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detected in the Msinga sub-district, the catchment area for the Church of Scotland Hospital (CoSH) in Tugela Ferry, in
KwaZulu-Natal province (KZN), South Africa. KZN is divided into 11 healthcare districts. We sought to determine the
distribution of XDR TB cases in the province in relation to population density.
Methods: In this cross-sectional study, the KZN tuberculosis laboratory database was analysed. Results of all patients with a
sputum culture positive for Mycobacterium tuberculosis from January 2006 to June 2007 were included. Drug-susceptibility
test results for isoniazid, rifampicin, ethambutol, streptomycin, kanamycin and ofloxacin were available for all patients as
well as the location of the hospital where their clinical diagnosis was made.
Findings: In total, 20858 patients attending one of 73 hospitals or their adjacent clinics had cultures positive for M.
tuberculosis. Of these, 4170 (20%) were MDR-TB cases. Four hundred and forty three (11%) of the MDR tuberculosis cases
displayed the XDR tuberculosis susceptibility profile. Only 1429 (34%) of the MDR-TB patients were seen at the provincial
referral hospital for treatment. The proportion of XDR-TB amongst culture-confirmed cases was highest in the Msinga sub-
district (19.6%), followed by the remaining part of the Umzinyati district (5.9%) and the other 10 districts (1.1%). The number
of hospitals with at least one XDR-TB case increased from 18 (25%) to 58 (80%) during the study period.
Interpretation: XDR-TB is present throughout KZN. More than 65% of all diagnosed MDR-TB cases, including XDR-TB
patients, were left untreated and likely remained in the community as a source of infection.
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Introduction
Multidrug-resistant (MDR) tuberculosis, including its extensive-
ly resistant (XDR) form has become a threat to the success of
tuberculosis control programs. MDR tuberculosis is now a global
epidemic with over 511000 estimated cases in 2007 [1].
In 2005, 53 cases of extensively drug-resistant (XDR) tubercu-
losis were detected in the Msinga sub-district, Umzinyati health
district, KwaZulu-Natal Province in South Africa (Fig. 1) [2].
All 53 were HIV infected. They sought healthcare at the
Church of Scotland Hospital (CoSH) in Tugela Ferry whose
catchment area is the Msinga sub-district. This raised the question
as to whether this was nosocomial transmission in CoSH, an
isolated outbreak in the Msinga community, or a widespread
epidemic involving other districts of KwaZulu-Natal Province.
The first indication that this was not an isolated nosocomial
outbreak in CoSH came from the observation that 30 of the 53
patients were identified through a survey amongst outpatients
suspected of having tuberculosis. Fourteen of the 30 had no prior
history of hospitalization [2]. While there was evidence of
nosocomial and community transmission, the question remained
as to how extensive the latter was. Since there was no obvious
reason why community spread should be restricted to the Msinga
sub-district, we hypothesised that XDR tuberculosis was present
throughout KwaZulu-Natal Province.
Methods
Study Design
This was a cross-sectional study, examining the culture and drug
susceptibility database of the provincial tuberculosis laboratory in
KwaZulu-Natal Province.
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Setting
KwaZulu-Natal Province has a population of 9.7 million (2003
census) [3] and is divided in 11 health districts (Fig. 1). According
to the provincial register, the incidence of tuberculosis in 2006 was
780 per 100,000 population. The HIV sero-prevalence among
antenatal attendees was 38% in 2006 [4].
KwaZulu-Natal Province has 74 public hospitals, with varying
numbers of affiliated clinics. Hospitals were grouped according to
Figure 1. Health districts of KwaZulu-Natal province and population density.
doi:10.1371/journal.pone.0017513.g001
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the district in which they are located. At the time of this study,
King George V Hospital (KGV) was the single MDR and XDR
tuberculosis referral hospital for patients in KwaZulu-Natal Prov-
ince. Patients confirmed as being infected with a MDR/XDR
strain of M. tuberculosis at one of the public hospitals or clinics, were
referred to King George V Hospital for further management.
TB culture and drug-susceptibility testing
The South African national guidelines for diagnosis of tubercu-
losis allow culture and drug-susceptibility testing to be performed
only on specimens from patients with a clinical diagnosis of tuber-
culosis who failed to respond to first-line therapy, who interrupted
treatment, who had a previous diagnosis of tuberculosis or had
repeatedly negative smear microscopy results. Adherence to these
guidelines depends on accessibility to diagnostic facilities. Of note,
after the report of XDR tuberculosis in 2005 [2], providers at
CoSH in the Msinga sub-district started to send specimens from all
patients suspected of tuberculosis for culture and drug-susceptibility
testing.
Drug-susceptibility test results were generated by the 1% pro-
portional method using Middlebrook 7H10 agar plates [5]. In
KwaZulu-Natal Province, routine susceptibility testing for M.tu-
berculosis includes the following drugs: isoniazid, rifampicin,
ethambutol, streptomycin, kanamycin and ofloxacin.
Data Source and Data Management
The drug-susceptibility profile of all M.tuberculosis isolates from
sputum, obtained from patients between 1 January 2006 and 30
June 2007 at the centralised TB laboratory in KwaZulu-Natal
Province, were analysed. Specimens from patients attending pri-
vate hospitals are not sent to this laboratory and therefore such
patients are excluded from this analysis.
If a patient had multiple isolates during the study period, those
with identical susceptibility profiles were regarded as a single
isolate. For patients with multiple isolates with varying suscepti-
bility profiles, only the most resistant isolate was selected. If
specimens from patients were received from more than one
hospital, then the most resistant isolate was used for analysis and
attributed to the hospital of first contact. Patients with missing
drug susceptibility data and/or hospital location were excluded
from this analysis. Numbers of MDR patients referred to KGV
Hospital were compared with the number of patients that were
diagnosed to ascertain referral and treatment rates. Data were not
available on clinical symptoms, tuberculosis treatment outcome,
new vs. re-treatment cases or HIV status.
Definitions
MDR tuberculosis was defined as resistance to isoniazid and
rifampin, with or without resistance to additional anti-tuberculosis
drugs. XDR tuberculosis was defined as MDR tuberculosis with
additional resistance to kanamycin and ofloxacin. The term MDR
tuberculosis includes XDR tuberculosis cases, unless specified
otherwise.
Statistical analysis
MDR and XDR tuberculosis proportion was calculated as
number of cases per 100 culture confirmed cases. The denomi-
nator to calculate the number of culture confirmed tuberculosis
cases was obtained from the KZN laboratory database. Population
data from the health statistics report of 2003 were used for the
calculation of incidence [3]. No accurate population data were
available for the study period. The incidence rates in two groups
are compared using an incidence rate ratio and the p-value is
calculated by assuming that under H0 the number of cases in
group 1 follows a binomial distribution with N= total number of
cases in both groups, and p=person-time in group1/total person-
time in both groups.
After excluding the Umzinyati district, the remaining districts
were separated into two groups which have distinctly different
proportions of XDR cases. These groups were found by se-
quentially pooling the districts and using Fisher’s Exact test to
determine if the proportion of XDR cases were not significantly
different across the districts within each group.
A generalized linear model (GLM) for the binomial family with
a log-link was fitted to the data to estimate the risk ratios
comparing the risk of XDR tuberculosis in different geographical
regions.
The data analysis was conducted using R version 2.11.0, The R
Foundation for Statistical Computing and STATAH 11.0,
StataCorp College Station, Texas.
Table 1. Incidence of culture-confirmed cases of newly-diagnosed tuberculosis, MDR tuberculosis and XDR tuberculosis in the 11
health districts of KwaZulu-Natal province.
District Population
Incidence of new TB
(per 100.000 person-yrs)
Incidence of MDR
(per 100.000 person-yrs)
Incidence of XDR
(per 100.000 person-yrs)
Amajuba 477,472 20.4 6 0.3
eThekwini 3,152,405 236.6 33.7 1.9
iLembe 571,686 103.9 19.1 1
Sisonke 304,409 103.8 20.6 2
uGu 718,221 72.7 23.8 0.9
uMgungundlovu 946,545 210.8 32.3 4
uMkhanyakude 584,898 111.6 50.8 0.3
Umzinyati 465,660 213 77.2 34.1
uThukela 670,226 39.6 6.8 0.8
uThungulu 903,822 76.9 21.8 1
Zululand 820,661 38.7 17.3 0.3
Total 9,616,005 144.6 28.9 3.1
doi:10.1371/journal.pone.0017513.t001
XDR Tuberculosis in KwaZulu-Natal
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Ethics Statement
The study was approved by the Biomedical Research Ethics
Committee at the University of KwaZulu-Natal (#BCA274/09).
As these samples were collected for routine clinical care, patients
were not asked to give informed consent at the time of the clinical
encounters. For the intentions of this study, there was no
requirement for informed consent since all data used were
previously collected during the course of routine medical care
and did not pose any additional risks to the patients.
Results
During the study period, M.tuberculosis was cultured from 20858
patients in KwaZulu-Natal Province. Of these, 4170 (20%) were
infected with MDR tuberculosis isolates. Four hundred and forty
three (11% of the MDR tuberculosis cases) displayed the XDR
tuberculosis susceptibility profile. Overall, 1429 (34%) of the MDR
tuberculosis cases were referred to KGV Hospital for further
management. This included 212 (48%) of all XDR tuberculosis
cases in the province during the study period.
The incidence of culture confirmed cases of tuberculosis in the
province was 144.6 per 100.000 person-years. However, this
varied widely between districts (Table 1). The highest incidence
was found in eThekwini (236.6/100.000 person-yrs) and the lowest
in Amajuba (20.4/100.000 person-yrs). The incidence of culture
confirmed MDR and XDR tuberculosis in the province was 28.9
and 3.1/100.000 person-years respectively (Table 1). The highest
incidence of both MDR (77.2/100.000 person-years) and XDR
(34.1/100.000 person years) tuberculosis was found in Umzinyati
district, which includes the Msinga sub-district. When the cases
found in the Msinga sub-district were removed from those in the
remainder of the district, the MDR incidence dropped to a level
comparable with other districts. However, the XDR incidence
remained at 5.0 versus 1.5/100.000 person years, significantly
higher (Incidence rate ratio: 3.36, p-value,0.0001).
The proportion of MDR cases among culture confirmed
patients with tuberculosis varied per district from 14.2% in
eThekwini to 45.6% in uMkhanyakude. Umzinyati district that
includes the Msinga sub-district, ranked third highest with 36.2%
(Table 2).
The proportion of XDR tuberculosis cases in the Umzinyati
district was 16%; this figure ranged from 0.3% to 2.0% in the
other 10 districts (Table 2). The proportion of XDR tuberculosis
in the Msinga sub-district was 19.6% vs 5.9% in the remaining
part of the Umzinyati district. This last figure is approximately 3
times higher than in the district with the second highest proportion
(Table 2).
When Umzinyati was excluded, the ten remaining districts
formed two distinct groups based on the proportion of XDR cases
(Table 3). Group 1 had an average proportion of XDR of 1.9%
(range 1.9 to 2.0) while in group 2 the average was 0.8% (range 0.3
to 1.4). Compared with the Umzinyati district (without Msinga
Table 2. Proportion of MDR and XDR cases of tuberculosis in the 11 health districts of KwaZulu-Natal province (as a proportion of
culture-confirmed TB cases).
District
Number of Culture
Confirmed TB cases
Proportion of MDR
(%) cases
Proportion of XDR
(%) cases
Amajuba 146 29.5 1.4
eThekwini 11188 14.2 0.8
iLembe 891 18.4 1
Sisonke 474 19.8 1.9
uGu 783 32.7 1.3
uMgungundlovu 2993 15.3 1.9
uMkhanyakude 979 45.6 0.3
Umzinyati 1488 36.2 16
uThukela 398 17.1 2
uThungulu 1042 28.4 1.3
Zululand 476 44.7 0.8
Total 20858 20 2.1
doi:10.1371/journal.pone.0017513.t002
Table 3. Health districts according to proportion of culture-confirmed XDR tuberculosis.
District
Number of Culture
Confirmed TB cases
Number of
XDR cases
Proportion of XDR
(%) cases
Msinga sub-district 1096 215 19.6
Umzinyati – without Msinga sub-district 392 23 5.9
Group 1- Sisonke, uMgungundlovu, uThukela 3865 74 1.9*
Group 2- uMkhanyakude, eThekwini, Zululand,
iLembe, uGu, uThungulu, Amajuba
15505 131 0.8**
*Range: 1.9–2.0;
**Range: 0.3–1.4.
doi:10.1371/journal.pone.0017513.t003
XDR Tuberculosis in KwaZulu-Natal
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sub-district), this translated to a Risk Ratio of 0.33 (95% CI 0.21–
0.51) and 0.14 (95% CI: 0.09–0.22) respectively (p,0.0001). All 3
districts in group 1 are adjacent to each other and located
southwest of Umzinyati. The 7 districts of group 2 are in the north
of the province and along the coast (Figure 1).
On the 1st of January 2006, patients infected with XDR
tuberculosis had been detected in 16 (22%) hospitals, which
increased to 58 (78%) by the end of June 2007. The geographical
distribution of this increasing number of hospitals over time is
shown in figure 2.
Discussion
We report on the temporal spread of XDR tuberculosis in
KwaZulu-Natal, the province of South Africa from which the first
report on XDR tuberculosis emerged [2]. The data show that in
Figure 2. Geographical distribution and increase in number of hospitals with at least one case of XDR tuberculosis between
January 2006 and June 2007. Each red dot depicts one hospital.
doi:10.1371/journal.pone.0017513.g002
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January 2006, XDR patients were detected in 16 hospitals located
in five provincial districts. By the end of the 18-month study pe-
riod, this figure extended to 58 hospitals involving all 11 districts.
The reported incidence of tuberculosis in 2006 in KZN was
780/100,000 [1]. We found the incidence of culture-confirmed
disease to be 145/100,000. This highlights the fact that over 80%
of reported cases of tuberculosis are not culture-confirmed and, by
default, also lack drug susceptibility test results. Although this may
be in keeping with the policy on diagnosis of tuberculosis in South
Africa, it is a matter of concern since a significant proportion of
patients with MDR/XDR tuberculosis are likely to die before it is
realized that drug susceptibility tests are needed to guide their
treatment. An additional concern is that more than 65% of MDR
(including XDR) cases of culture-confirmed tuberculosis did not
reach the referral centre and therefore remained untreated. These
large groups of undiagnosed and diagnosed-but-not-referred cases
of drug-resistant tuberculosis form a contingent of patients whose
disease is inappropriately managed. They also represent a pool of
potential transmitters of drug-resistant tuberculosis in the com-
munity or in hospitals.
The last drug resistance survey in South Africa in 2001/2002
found that the MDR tuberculosis prevalence in KwaZulu-Natal
was 1.7% among new patients and 7.7% among retreatment
patients. This was similar to other provinces [6]. Second-line drug
susceptibility testing was not performed in this survey and therefore
the proportion of XDR cases is unknown. However, XDR was
already present in KwaZulu-Natal Province in 2001 [7]. We show
an overall increase in the proportion of culture-confirmed MDR to
20% (Table 1). However, this figure cannot be compared with
those found during the 2001/02 survey. The reported prevalence
in 2001/02 is based on active case finding in randomly chosen
areas in the province and reflects the situation amongst all patients
with tuberculosis. Our figures represent only the proportion
amongst culture-confirmed cases in the province and are therefore
a gross underestimation of the total number of MDR cases in KZN.
Despite this underestimation, we show a doubling of MDR cases
over the 5-year period from 2001/02 to 2006.
The proportion of culture-confirmed XDR tuberculosis in the
Umzinyati district was more than seven times higher than that in
the rest of the province. Although this was largely attributable to
the high prevalence in the Msinga sub-district where all suspected
cases are cultured, the observation that the remaining part of the
Umzinyati district with culture practices comparable to the other
districts also had a higher proportion of XDR cases than the rest of
the province (Table 3) alludes to circumstances in that district that
may have facilitated the emergence of XDR tuberculosis.
The data also show that the presence of XDR tuberculosis is not
restricted to the Umzinyati district. Although the proportion of
XDR amongst culture-confirmed cases is lower in the other
districts (Table 2), this might not reflect the real situation. Patients
with tuberculosis from the Msinga sub-district obtained a diagnosis
through culture and drug susceptibility testing on first presenta-
tion. As a result, a diagnosis of drug-resistant tuberculosis was
already made even if patients died in the ensuing weeks. In the rest
of the province, cultures were done when there was no response to
treatment. As many patients with XDR tuberculosis die within
weeks from first presentation [2], a significant number of patients
in other parts of the province may have remained undiagnosed.
Whole genome sequencing data on a limited number of ran-
domly chosen XDR isolates from KwaZulu-Natal Province
suggest that one XDR strain has spread throughout the province
[8]. This needs confirmation by sequencing of a larger number of
isolates. The observation that the proportion of XDR cases in the
Umzinyati district (even without Msinga) is higher than that in the
other districts suggests that this may be the source of such clonal
spread. This is supported by the observation that the three districts
in the southwest of the province had a higher proportion of XDR
patients as compared to the other districts. Like the communities
of Umzinyati, people from these districts use Pietermaritzburg as
their main shopping and cultural centre. The other districts use
Durban and Empangeni for that purpose. The observed temporal
increase of XDR throughout the province during the study period
also supports the possibility of clonal spread. However, this is a
retrospective study and no concrete conclusions can be made
regarding the true nature of the acquisition and spread of TB in
this group of patients.
Since there is not, as yet, effective treatment for XDR tuber-
culosis, tuberculosis control programmes need to include more
effective strategies to curb its spread. A rapid and efficient
implementation of the new national guidelines for the initiation of
anti-retroviral treatment at a CD4 count of 350/mm3 as opposed
to 200/mm3 would assist in decreasing the size of the susceptible
population [9]. In addition, the infection prevention strategies to
limit transmission in health care facilities as well as in the
community need to be implemented and evaluated. Without this,
the implementation of the new policy of combined care for
patients with active tuberculosis and HIV infected patients without
tuberculosis is likely to promote further spread of tuberculosis. The
development of a rapid diagnostic test that is able to detect the
presence of M. tuberculosis and its susceptibility to first-line and
second-line drugs within a couple of hours should have the highest
priority. Such a test will be able to identify MDR and XDR cases
much earlier and facilitate more efficient management of this
disease and earlier implementation of strategies to prevent trans-
mission of drug-resistant tuberculosis.
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